Advertisement
Screener

NRX Pharmaceuticals, Inc. (NRXP) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

NRX Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where NRX Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $14.11M went out.
  • Fiscal year ended 2025-12-31: from investing, $2.81M went out.
  • Fiscal year ended 2025-12-31: from financing, $23.28M came in.
  • Fiscal year ended 2025-12-31: change in cash, $6.35M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$14.11M-$2.81M$6.39M$16.88M*$6.35M
2025-09-30-$12.50M*-$2.56M*$4.75M*$15.85M*
2024-12-31-$10.64M$0.00$0.00$7.49M*-$3.15M
2024-09-30-$11.73M*$1.00K*$4.47M*
2023-12-31-$21.66M-$3.00K$6.20M*-$15.46M
2023-09-30-$26.78M*-$3.00K*$17.44M*
2022-12-31-$39.76M-$10.00K$10.00K$32.20M*-$7.55M
2022-09-30-$42.72M*-$11.00K*$22.09M*
2021-12-31-$37.70M-$7.00K$63.46M*$25.75M
2021-09-30-$26.83M*-$26.22M*-$18.26M*$82.70M*$37.60M*
2020-12-31-$2.27M-$2.00K$3.25M*$982.00K
2020-09-30-$2.12M*$35.85M*-$7.31M*$216.06K*
2019-12-31-$792.73K$40.25M-$40.73M$1.26M*-$11.07K
2019-09-30-$601.54K*$29.92M*-$29.20M*$117.19K*
2018-12-31-$473.19K-$647.39K$0.00$682.50K*-$438.30K
2018-09-30-$30.00$0.00$25.00K$82.47K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$8.88M*-$684.00K*$29.53M*
2026-03-31-$4.29M-$213.00K$3.42M-$1.08M
2025-12-31-$3.71M*-$249.00K*$1.64M*$2.93M*
2025-09-30-$2.89M*-$2.56M*$3.74M*$5.99M*
2025-06-30-$4.03M*$0.00*$1.01M*
2025-03-31-$3.48M$0.00$0.00$7.58M*$4.11M
2024-12-31-$2.10M*$0.00*$0.00*$1.90M*
2024-09-30-$2.31M*$0.00*$0.00*$2.05M*
2024-06-30-$2.56M*$0.00*$3.14M*
2024-03-31-$3.67M$0.00-$3.28M
2023-12-31-$3.19M*$1.00K*-$1.12M*
2023-09-30-$4.56M*-$2.00K*-$1.50M*
2023-06-30-$7.81M*$2.00K*$6.27M*
2023-03-31-$6.09M-$4.00K$2.54M*-$3.55M
2022-12-31-$8.32M*$1.00K*$10.12M*
2022-09-30-$6.27M*-$5.00K*
2022-06-30-$14.79M*-$3.00K*-$860.00K*
2022-03-31-$10.38M-$3.00K$22.98M*$12.60M
2021-12-31-$11.28M*$0.00*-$11.28M*
2021-09-30-$12.01M*-$4.00K*$1.13M*$36.38M*$25.50M*
2021-06-30-$11.39M*-$3.00K*$1.56M*$9.95M*$11.53M*
2021-03-31-$3.02M$0.00$6.93M$7.50M*-$234.00
2020-12-31-$406.71K*-$26.21M*-$27.89M*$28.87M*$571.66K*
2020-09-30-$1.13M*$306.13K*-$299.25K*$1.41M*$291.77K*
2020-06-30-$651.84K*-$23.22K*$0.00*$26.17M*$37.80K*
2020-03-31-$76.43K$25.93M-$26.00M$80.77K
2019-12-31-$262.07K*$9.64M*-$9.58M*-$194.27K*
2019-09-30-$52.31K*$8.93M*-$8.89M*$192.89K*
2019-06-30-$180.65K*$22.18M*-$22.10M*-$424.00*
2019-03-31-$297.70K-$508.21K$0.00$796.64K*-$9.26K
2018-12-31-$70.88K*-$684.91K*$0.00*$690.00K*-$66.01K*
2018-09-30-$67.40K*$4.88K*$0.00*-$62.53K*
2018-06-30-$137.08K*$9.51K*-$127.58K*
2018-03-31-$197.82K$23.13K-$182.18K
2017-12-31-$135.81K-$69.00M$25.00K$69.56M*$449.37K

Similar stocks

Stock NameCountryMarket CapPE Ratio
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95